Learn More
Learn More
Learn More
Learn More
Learn More
Home » Sustainability
Adhering to the corporate mission to “Make People and Nature Healthier through Biotechnology”, GenScript integrates sustainability into strategic planning. While driving stable growth across our business portfolio, we also strive to improve our environmental, social and governance performance. Along with our global business partners, clients, suppliers and all other stakeholders, we aim to make a positive impact and give back to society.
A signatory of the United Nations Global Compact (UNGC)
Decarbonization targets approved by the Science Based Targets Initiative (SBTi)
Pharmaceutical Supply Chain Initiative (PSCI) Supplier Partner
Received an A rating from MSCI ESG Ratings
Awarded a bronze medal by EcoVadis, placing GenScript in the top 17% of all assessed companies
Received a B rating for Climate Change from CDP
31% operational sites certified to ISO 14001 certification
GHG reduction targets validated by SBTi:
83% suppliers with SBTi targets by 2029
54.6% reduction in Scope 1 & 2 emissions by 2033
Net-zero across Scope 1, 2 & 3 by 2025
58% female employees
48% women in managerial positions
100% employees with professional development training
53 new patents granted
Cumulatively 254 patents granted
51 volunteer campaigns
1,408 volunteer service hours
100% employees and Board members trained on business ethics
100% Supplier Code of Conduct sign-off
Find our ESG Report to learn more about our sustainability progress.
Learn more about policies, codes, guidelines and commitments that guide our ESG practices.
Please contact us at ESG@genscript.com if you have any questions about our ESG reports or initiatives.